T he bestrophinopathies are a group of inherited eye disorders that arise from either dominant or recessive mutations in the BEST1 gene. The clinical spectrum of disorders include (1) diseases predominantly affecting the macula-Best disease (BD) and adult vitelliform macular dystrophy; (2) generalized retinal involvement-autosomal dominant vitreoretinochoroidopathy and retinitis pigmentosa; and (3) diseases with retinal and anterior segment involvement-autosomal recessive bestrophinopathy (ARB) and microcornea, rod-cone dystrophy, cataract, and posterior staphyloma. [1] [2] [3] [4] [5] [6] [7] In addition to the phenotypic heterogeneity, some of the bestrophinopathies display significant variation in penetrance of the clinical phenotype. 8 However, one endophenotype, the absent or reduced electrooculogram (EOG) light rise, is reported to be almost fully penetrant. 9 This electrophysiologic parameter arises as the cornea is positively charged relative to the negative retina thus creating a dipole through the eye that can be measured with surface electrodes. The light rise reflects a progressive depolarization of the basal membrane of the retinal pigment epithelium (RPE) in response to a change from scotopic to photopic adaptation. Although the underlying molecular basis for the change in EOG with illumination is not known, it is almost always reduced in patients with BEST1 mutations. The present report investigates the EOG findings in a large cohort of patients with BD and ARB.
Methods
A retrospective review of the genetic database at Moorfields Eye Hospital, London, United Kingdom was undertaken to identify all patients with either biallelic or heterozygous mutations in BEST1 and a compatible clinical phenotype. Within this group, only those who had undergone electrophysiologic testing at our own institution were investigated further. Patients with a normal or atypical EOG light rise were then identified.
The EOG testing was performed to be consistent with International Society for Clinical Electrophysiology of Vision (ISCEV) standards. 10 Normative EOG data were obtained by testing 30 individuals aged between 30 and 60 years with no known ocular abnormalities. One eye from each normal subject was randomly selected and used to establish the normative data. In brief, EOG testing was performed with surface electrodes placed at the medial and lateral canthi of each eye. Thirty degree eye movements were recorded for 10 seconds of each minute during 15 minutes of dark adaptation, followed by a further 10 to 15 minutes in full-field (Ganzfeld) light adaptation (100 cd/m 2 ). The amplitudes of the light peak and dark trough were directly measured and the light peak:dark trough ratio was expressed as a percentage. Pattern electroretinograms (PERGs) and full-field electroretinograms were used to assess macular function and generalized retinal function, respectively. 11, 12 All clinical electrophysiologic assessments were analyzed by one of two consultant electrophysiologists (G.H. or A.R.) masked to the molecular diagnosis.
A clinical diagnosis was made based on the fundoscopic appearance together with findings on optical coherence tomography and fundus autofluorescence (excitation wavelength 488 nm; Spectralis, Heidelberg Engineering, Heidelberg, Germany). A genetic diagnosis was determined by DNA sequencing (Manchester Regional Genetics Laboratory). Genomic DNA was extracted from the peripheral blood (Qiagen Blood DNA extraction kit; Qiagen, Crawley, United Kingdom) and used as the template for bidirectional Sanger sequencing analysis of the entire coding regions of BEST1, including the splice donor and acceptor sites.
Results
The EOG Arden ratios in the normal subjects ranged from 180% to 435% (median 267%, SD 50% n = 30). For this study, we considered an Arden ratio of less than 165% to be abnormal (2 SDs below the mean).
A total of 113 patients were identified with likely disease-causing sequence variants in BEST1 (99 BD and 14 ARB). Electrophysiologic testing had been performed in 75 patients. Three groups were identified. Twenty patients (27%) had no detectable light rise (Arden ratio of 100%), whereas 49 cases (65%) had Arden ratios of between 100% to 165%. Six patients (8%) were found to have an EOG light rise of .165% and will be described in detail below. No cases were identified with sufficient asymmetry in Arden ratios to cause eyes of the same patient to be categorized differently.
Patient 1 was diagnosed with BD aged eight based on bilateral typical macular vitelliform lesions. He later presented with reduced vision in his right eye due to macular scarring from a presumed occult choroidal neovascular membrane and underwent EOG testing at age 39. Arden ratios were 220% right and 180% left. Full-field electroretinograms were normal and symmetrical, indicating no evidence of generalized retinal dysfunction. Pattern electroretinogram P50 component was mildly subnormal on the right consistent with mild right macular dysfunction. The diagnosis of BD was thereby questioned and PRPH2 gene screening was initiated but no pathogenic variants were identified. BEST1 screening revealed a heterozygous missense amino acid substitution (p.Arg25Trp) previously associated with BD. 13 Patient 2 was diagnosed with BD as a teenager when her vision deteriorated in both eyes. The diagnosis was questioned when she was seen between the ages of 28 to 36 because of an atypical macular appearance. Optical coherence tomography imaging demonstrated focal choroidal excavation alongside subretinal deposit and fluid. The full-field electroretinogram was normal, but the PERG P50 component was reduced, left more than right in keeping with macular dysfunction. Eye movement artefacts disrupted accurate grading of the EOG, but an adequate light rise and dark trough were noted; consequently, this patient was reported to have a normal EOG and included in this cohort. Screening BEST1 identified the variant p.Lys30Asn, predicted to be damaging as this residue is highly conserved (PolyPhen2 score 1.0).
Although the EOG was reported as normal, accurate quantification of the Arden ratio had not been possible. As part of this study, the EOG was then repeated 12 months later; this time a reduced light rise with an Arden index of 120% in each eye was recorded, consistent with the diagnosis of BD.
Patient 3 was diagnosed in his youth with a macular dystrophy that resembled BD. He was part of a consanguineous pedigree with a similarly affected brother living abroad. When he was examined at age 41, the right macula was found to be atrophic and the left showed subfoveal fluid and subretinal deposit ( Figure 1 ). The EOG light rise-to-dark trough ratio was 175% on the right and 260% on the left. The PERG P50 component was bilaterally subnormal in keeping with macular dysfunction. Full-field electroretinograms were normal. BEST1 gene screening identified the homozygous variant p.Arg47Cys, previously shown to cause ARB, also with a vitelliform rather than multifocal phenotype. 14, 15 Patient 4 was diagnosed with BD at age nine based on a vitelliform maculopathy and dominant family history. The EOG light rise-to-dark trough ratio was 180% bilaterally. There was PERG evidence of mild left macular dysfunction. Full-field electroretinograms were normal bilaterally. Screening of BEST1 revealed a previously reported heterozygous mutation p.Tyr85His. 16 Patient 5 was diagnosed in childhood with BD and was examined again at the age of 33. She had a small vitelliform lesion in her right eye and a petaloid arrangement of subretinal deposit in her left eye in keeping with a reticular pattern dystrophy-like phenotype. No similarly affected family members were known. The full-field electroretinogram and PERG were normal, and her EOG light rise-to-dark trough ratio was 175% on the right and 180% on the left. DNA sequencing identified a BEST1 variant (p.Ala243Val) already known to cause disease BD. 3 Patient 6 had a history of poor vision from the age of 12 and was found to be hyperopic at the age of 20 year. His left eye was amblyopic. Both his parents had good vision into their seventh decade. By the age of 37, his vision had declined to hand movement in the right eye and 1/60 in the left eye. He was diagnosed with BD after retinal examination revealed a vitelliform maculopathy in his right eye and well-defined atrophy in the left (Figure 2 ). The full-field electroretinogram was normal, but the PERG was reduced. The EOG light rise was recorded at 200% in each eye. Screening the genes PRPH2 and BEST1 identified p.Leu567Phe in BEST1 as the only likely pathologic variant. This variant has been previously reported as a possible cause of late adulthood-onset retinal dystrophy and theoretically is sufficiently rare to cause BD (0/61730511, Exome Aggregation Consortium [ExAC] database). 17, 18 As it remains questionable whether this variant accounts for the maculopathy present in Patient 6, whole genome sequencing is being used to elucidate the genetic cause.
Discussion
In this cohort of patients with molecularly proven BD or ARB, four individuals (5.4%) were found to have a normal or greater EOG light rise than usually seen in the bestrophinopathies. This was a higher number than expected, as although BEST1 mutations are associated with varied expression of the fundus phenotype, it is considered a rarity that the EOG light rise remains unaffected, with only a few individual cases reported. 3, [13] [14] [15] [19] [20] [21] [22] [23] [24] The present findings, when combined with published data, demonstrate that of the 269 unique BEST1 mutations thus far collated, at least 3.3% have now been associated with a greater than expected EOG amplitude (Table 1) . 25 In collecting these data, we are able to highlight two potential reasons whereby erroneous conclusions may be made when interpreting the results of either electrophysiologic or genetic testing. First, inaccurate saccadic eye movements in Patient 2 produced the illusion of a falsely high Arden ratio. This was noticed by careful review of the traces and corrected by retesting. Second, pathogenicity has probably been wrongly assigned to the variant p.Leu567Phe identified in Patient 6; given that it has only been seen twice before (and only in the context of age-related macular degeneration), is not a highly conserved residue, and when modeled in vitro does not alter chloride conductance or channel permeability to anions. 26, 27 This case highlights the increasing challenge that is faced in definitively ascribing disease causation to identified sequence variants, especially for missense mutations.
Why a subgroup of patients retain a light rise is currently unknown. Theoretically, it is possible that they represent a group who, in the absence of a mutation, would have recorded an unusually high light rise. Therefore, while the effects of mutation result in a reduction of amplitude, this only serves to bring it to the lower end of the normal range. Data derived from testing normal individuals herein shows a more than two-fold difference between the lowest and highest Arden ratios (180%-435%) and the authors do have experience of at least one normal subject with a light rise of more than 500% (unpublished data). Given these findings, it is likely that genetic modifiers exist which may influence the EOG amplitude, either by effects on BEST1 itself or interacting proteins. One hypothesis, that may also underpin the variation in fundus expression, proposes that a normal EOG may result from relatively higher expression of the wild-type compared with mutant allele. Although allelic imbalance is a plausible explanation for dominant disease, it would be harder to argue in cases of recessive inheritance, where the ability to maintain a light rise must depend on the presence of some retained BEST1 function. Recessive alleles are thought to be functionally null; however, this may not always be the case. The p. Arg47Cys mutation (Patient 3 in our series) has now occurred with relatively mild EOG on three independent occasions and in different ethnic populations. 14, 15 An additional atypical finding in these cases is the presence of unifocal disease, as recessive disease is usually more widespread. It is possible that these alleles are hypomorphic and retain sufficient function to support anion transport across the basolateral surface of the RPE, thus maintaining an EOG light rise and at the same time having enough function to limit the disease to the macula. The same mechanism may also be proposed for the recessive c.1100+1 G . A allele, suggesting that aberrant spicing does affect all transcripts. 24 Interestingly, all the mutations that have been associated with a normal EOG have also been described in individuals with a poor or absent light rise on EOG. This variability has been observed in members of the same family, again suggesting the influence of genetic or environmental modifiers. 23 Some variants however are overrepresented within the normal EOG group, particularly the p.Ala243Val mutation. Of 42 unique heterozygous mutations identified in this cohort, p.Ala243Val was the second most commonly reported (n = 6), the most prevalent being p.Arg218Cys (n = 10). Although this could suggest that the association with a normal EOG is a chance finding, others have also reported this genotype with a normal Arden ratio (Table 1) . If chance alone were acting, one would expect that the most commonly encountered mutation (p.Arg218Cys) would be most often associated with a normal Arden ratio. This has only been described once before, and in our series, this genotype always had an abnormal EOG. 19 The ability to generate a light rise therefore may in some cases be strongly influenced by the genotypes (p.Arg47Cys and p.Ala234Val) whereas other factors, yet to be determined, are responsible for the remainder.
Although the molecular basis supporting the light rise of the EOG is yet to be established, our understanding of conditions that may alter it has advanced. The polarized RPE is thought to generate and maintain a potential difference across its surface, and this can be affected in both health and disease. [28] [29] [30] In the presence of light, the conduction of anions across the basolateral RPE membrane is thought to increase, resulting in depolarization and a rise in the recorded potential difference. This process may be pharmacologically manipulated, as lamotrigine and acetazolamide have both been shown to reduce the amplitude of the EOG light rise. [31] [32] [33] In addition, the stimulus for the light rise does not need to be photic, because alcohol (supplied by the choroidal circulation) simulates this phenomenon. 30 In the disease state, the RPE may either not be able to maintain its polar properties due to disorganization of tight junctions or may not be able to pump anions efficiently or as normally directed. This is the supposition in cases of BD and in some cases of acute zonal occult outer retinopathy in which the EOG is severely affected. 34 To gain a better understanding of the underlying pathology, Singh et al generated an induced pluripotent stem cell (iPS) model for BD. 35 Initially, RPE cells derived from patients with BD showed no differences from control induced pluripotent stem cellretinal pigment epithelium cells; however, after exposure to a stressor, BD induced pluripotent stem cell-retinal pigment epithelium cells demonstrated reduced phagocytosis and accumulation of autofluorescent material. 35 Although in vivo all RPE cells should be equally susceptible to the effects of mutation, it may be that only RPE cells responsible for maintaining the foveal photoreceptors are sufficiently stressed to demonstrate functional abnormalities, as subretinal deposit rarely accumulates outside the macula in BD. Because both the amplitude of the light rise and the presence of maculopathy can be individually and independently expressed, the underlying mechanisms may be divergent. The processes responsible for generating the EOG are less likely to involve the phagocytic pathway but may be calcium dependent, as BD induced pluripotent stem cell-retinal pigment epithelium cells exhibit altered endoplasmic reticulum-dependent calcium currents when compared with control cells. 35, 36 Indeed, it has been suggested that the RPE acting alone can respond to photic stimulation, generating an increase in inositol triphosphate, resulting in calcium release from the endoplasmic reticulum into the cytosol, followed by transport of chloride ions across the basolateral RPE membrane. 37 Restoration of intracellular calcium levels is thought to require both L-type calcium channels and BEST1, acting to transport chloride as a counter ion. 38 Recently, it has been suggested that there is a dynamic relationship in the distance between the photoreceptor outer segment and the inner surface of the RPE, so called "outer segment equivalent length" (OSEL), such that, in the light, the two are closely approximated, whereas in the dark, they lay further apart. 39 Abramoff et al suggest that these morphologic changes have a similar time course to the EOG changes in light and dark and that these changes are abolished and even reversed in patients with BD and an abnormal EOG, where there is chronic OSEL lengthening rather than shortening in response to light. 39 They suggest that one role of BEST1 is to enable the approximation of the RPE and photoreceptor outer segment thus enhancing the efficiency of phagocytosis. We now propose an alternative hypothesis that BEST1 facilitates pigment granule migration within the RPE. In the darkadapted state, Johnson et al have shown that these granules aggregate toward the base of the cell. 40 Under such conditions, optical coherence tomography measurement of OSEL would represent the distance from the ellipsoid zone to the lower half of the RPE (where the pigment granules reside). In the light, the granules disperse, mediated by a calcium-dependent The data are ordered based on the position of the mutant residue. The current work (Patients 1, 3, 4, and 5) is presented alongside previously reported studies. In all cases testing incorporated the relevant ISCEV standards of the time.
mechanism, and now preferentially reside within the apical processes of the RPE. 40 The OSEL would now be correspondingly shorter, and this shortening would be determined by pigment migration rather than the length of the photoreceptor outer segment. In BD, dysfunctional BEST1 protein within the endoplasmic reticulum would disrupt normal calcium homeostasis, resulting in less pigment dispersion and reduced migration to the apical processes. 40 Accordingly, the OSEL would not be expected to reduce in BD as observed in the original study. 39 BEST1 function is therefore thought to be critical for multiple but independent cellular processes, probably indirectly mediated by its ability to regulate intracellular calcium levels. The effects of mutation are correspondingly diverse. First, it can reduce lightinduced chloride efflux at the basolateral surface of the RPE (most likely through TMEM16A calcium-gated chloride channels), as mutant BEST1 channels may result in reduced endoplasmic reticulum calcium stores. If these stores are replenished through a different pathway, chloride efflux may still be supported, and an EOG light rise may be generated. Second, BEST1 mutation can reduce photoreceptor outer segment phagocytosis, a process similarly controlled by intracellular calcium. Third, altered pigment granule migration is thought to be calcium dependent and is worthy of further investigation as a novel endophenotype in BD. The current work now provides clinical evidence that the EOG phenotype is more variable than once thought. As the calcium-sensitive chloride channels, phagocytic process, and pigment granule migration pathways are all likely to have differential calcium sensitivities, it is perhaps not surprising that patients with BEST1 mutations show such variation in disease expression.
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